Imexpharm Corporation (HOSE:IMP)

Imexpharm Revenue

Imexpharm had revenue of 546.21B VND in the quarter ending March 31, 2026, a decrease of -8.06%. This brings the company's revenue in the last twelve months to 2.39T, up 3.69% year-over-year. In the year 2025, Imexpharm had annual revenue of 2.44T with 10.70% growth.

• Revenue (ttm): 2.39T
• Revenue Growth: +3.69%
• P/S Ratio: 3.27
• Revenue / Employee: 1.66B
• Employees: 1,444
• Market Cap: 7.82T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.44T	235.97B	10.70%
Jan 1, 2025	2.21T	211.08B	10.59%
Jan 1, 2024	1.99T	350.33B	21.31%
Dec 31, 2022	1.64T	377.11B	29.77%
Dec 31, 2021	1.27T	-102.83B	-7.51%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 29, 2026

Data Sources Report a data error